COCP · Categories · Form 4

COCP - SEC Form 4 insider transactions

Cocrystal Pharma Inc. (COCP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for COCP

• 44d
  SEC Form 4 filed by Chief Executive Officer Sapirstein James

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Director Kornberg Roger D.

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by President and Co-CEO Lee Sam

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Director Pfenniger Richard C Jr

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Director Hassan Fred

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Co-CEO and CFO Martin James Joseph

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Director Japour Anthony J

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Director Frost Phillip Md Et Al

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 185d
  SEC Form 4 filed by Director Rubin Steven D

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 260d
  Director Hassan Fred was granted 359,713 shares, increasing direct ownership by 35% to 1,383,009 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 260d
  Director Pfenniger Richard C Jr was granted 20,000 shares, increasing direct ownership by 175% to 31,400 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 260d
  Director Frost Phillip Md Et Al was granted 359,713 shares (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 260d
  Co-CEO and CFO Martin James Joseph was granted 3,598 shares, increasing direct ownership by 9% to 44,167 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Director Kornberg Roger D. was granted 28,109 shares (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Director Frost Phillip Md Et Al was granted 27,100 shares (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  President and Co-CEO Lee Sam was granted 40,000 shares, increasing direct ownership by 110% to 76,355 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Co-CEO and CFO Martin James Joseph was granted 40,000 shares, increasing direct ownership by 7,030% to 40,569 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Director Pfenniger Richard C Jr was granted 8,067 shares, increasing direct ownership by 242% to 11,400 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Director Rubin Steven D was granted 18,957 shares, increasing direct ownership by 0.72% to 2,660,242 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Director Hassan Fred was granted 8,067 shares, increasing direct ownership by 0.79% to 1,023,296 units (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 644d
  Director Japour Anthony J was granted 14,924 shares (SEC Form 4)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Frost Phillip Md Et Al

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Martin James Joseph

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Japour Anthony J

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Pfenniger Richard C Jr

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Kornberg Roger D.

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Lee Sam

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Rubin Steven D

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1093d
  SEC Form 4 filed by Hassan Fred

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1198d
  SEC Form 4 filed by Frost Phillip Md Et Al

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Japour Anthony J

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Frost Phillip Md Et Al

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Martin James Joseph

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Rubin Steven D

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Pfenniger Richard C Jr

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Kornberg Roger D.

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1444d
  SEC Form 4 filed by Lee Sam

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1789d
  SEC Form 4: PFENNIGER RICHARD C JR bought $41,120 worth of Common Stock (40,000 units at $1.03)

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by FROST PHILLIP MD ET AL

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by Cocrystal Pharma, Inc.

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by Martin James Joseph

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by Kornberg Roger D.

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by PFENNIGER RICHARD C JR

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by Lee Sam

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1823d
  SEC Form 4 filed by Japour Anthony J

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)
• 1898d
  SEC Form 4: Schinazi Raymond F sold $1,696,250 worth of Common Stock (575,000 units at $2.95), decreasing direct ownership by 7% to 7,674,960 units

  4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)

Other COCP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends